The New England Journal of Medicine
暂无分享,去创建一个
J. | D. Van | Ijver | Orien | V. W. | Oskuil | Eorge | S. J. | Chreiber | Ohannes | P. L. | Eterse | atthew | M. J. | Árton
[1] Christine Solbach,et al. Identification of high risk breast-cancer patients by gene expression profiling , 2002, The Lancet.
[2] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[3] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. J. Wei,et al. The Robust Inference for the Cox Proportional Hazards Model , 1989 .
[5] C. Isaacs,et al. New prognostic factors for breast cancer recurrence. , 2001, Seminars in oncology.
[6] M Markman,et al. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute. Monographs.
[7] P. Grambsch,et al. Martingale-based residuals for survival models , 1990 .
[8] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[9] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[10] René Bernards,et al. A progression puzzle. , 2002, Nature.
[11] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[12] Yudong D. He,et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.
[13] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[14] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[15] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[16] R. Gelber,et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] Robert J. Mayer,et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.
[19] D.,et al. Regression Models and Life-Tables , 2022 .
[20] D. Tripathy,et al. Tamoxifen for early breast cancer: An overview of the randomised trials , 1999 .
[21] J. Klein,et al. Small sample moments of some estimators of the variance of the Kaplan−Meier and Nelson-Aalen estimators , 1991 .